dc.contributor | Tornero Molina, J., Departamento de Medicina, Universidad de Alcalá, Hosp. Gen. Univ. de Guadalajara, Guadalajara, Mexico, Servicio de Reumatología, Hosp. Gen. Univ. de Guadalajara, Donantes de Sangre, s/n, 19002 Guadalajara, Mexico | |
dc.creator | Tornero Molina, J. | |
dc.date.accessioned | 2015-11-19T18:52:39Z | |
dc.date.accessioned | 2023-07-04T02:21:04Z | |
dc.date.available | 2015-11-19T18:52:39Z | |
dc.date.available | 2023-07-04T02:21:04Z | |
dc.date.created | 2015-11-19T18:52:39Z | |
dc.date.issued | 2003 | |
dc.identifier | http://hdl.handle.net/20.500.12104/67988 | |
dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-0038657778&partnerID=40&md5=22a2f8ed76c9a46d2383508585463975 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/7261289 | |
dc.description.abstract | The use of nonsteroidal antiinflammatory drugs (NSAID) combined with oral anticoagulants (OA) has the risk of interactions that could increase the risk of bleeding complications. A review of the mechanisms and clinical significance of these adverse interactions between NSAIDs, including the new COX-2 specific inhibitors (COXIB), and OA, is discussed. | |
dc.relation | Seminarios de la Fundacion Espanola de Reumatologia | |
dc.relation | 4 | |
dc.relation | 2 | |
dc.relation | 62 | |
dc.relation | 65 | |
dc.relation | Scopus | |
dc.title | Diclofenac is the NSAID that an anticoagulated patient should take [El AINE que debe tomar el paciente anticoagulado es el diclofenaco] | |
dc.type | Review | |